FDA.reportPublic FDA data

ruxolitinib (as ruxolitinib phosphate) 10 MG Oral Tablet

RxCUI
1193331
RxNorm name
ruxolitinib (as ruxolitinib phosphate) 10 MG Oral Tablet
Display name
ruxolitinib (as ruxolitinib phosphate) 10 MG Oral Tablet
Full name
ruxolitinib (as ruxolitinib phosphate) 10 MG Oral Tablet
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:27

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
JAKAFIRUXOLITINIBIncyte Corporationf1c82580-87ae-11e0-bc84-0002a5d5c51b2026-07-20Warnings, Adverse reactionsExact identifier
rxcui: 1193331

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
f1c82580-87ae-11e0-bc84-0002a5d5c51bruxolitinib 10 MG Oral Tablet [PSN] · ruxolitinib 10 MG Oral Tablet [SCD] · ruxolitinib (as ruxolitinib phosphate) 10 MG Oral Tablet [SY]340These highlights do not include all the information needed to use JAKAFI/JAKAFI XR safely and effectively. See full prescribing information for JAKAFI/JAKAFI XR. JAKAFI ® (ruxolitinib) tablets, for oral use JAKAFI XR™ (ruxolitinib) extended-release tablets, for oral use Initial U.S. Approval: 201120260501